Rocket Lab shares drop over 9% after stock remains below key moving averages

Rocket Lab shares drop over 9% after stock remains below key moving averages
Rocket lab slides 9.16% today

Rocket Lab Corporation (RKLB) slumped 9.16% on a sharp surge in selling pressure and strongly negative momentum, driving the stock down after a substantial downward gap at the open. The move is reinforced by the stock remaining below its short- and medium-term moving averages and ongoing weakness across key technical indicators.

RKLB price prediction
24H -0.85%
$56.88
48H -2.65%
$55.85
7D -3.1%
$55.59
1M 13.93%
$65.36
3M 12.6%
$64.6
6M -2.91%
$55.7
12M 0.89%
$57.88
Current price: $57.37 -4.0600 6.61%
Closed 11/16
Daily range 57.23 Arrow from to Icon 61.87
Weekly range 55.11 Arrow from to Icon 68.18
Loading...

Highlights

  • Rocket Lab is under short- and medium-term selling pressure, trading below key moving averages with price near intraday lows.
  • Momentum indicators confirm a bearish bias, with oversold conditions prevailing and intraday volatility elevated above 9%.
  • Over the next week, price is likely to drift sideways between $76.19 support and $92.21 resistance, with downside risk exceeding 80%.
Anton Kharitonov, expert at Traders Union, notes the sharp loss in Rocket Lab as confirmation of deep-seated technical weakness. He highlights that technical signals remain bearish, with the stock locked below key averages and a lack of supportive sentiment or fresh news catalysts. Kharitonov is particularly wary of the sharply negative MACD and muted trend momentum, which signal potential for further declines despite some intraday stabilization. The move below $90.44 resistance reinforces a cautious outlook short term. "With ongoing sell signals and absent positive drivers, I see elevated downside risk — caution is paramount for now."
Viktoras Karapetjanc, expert at Traders Union, sees Rocket Lab’s price action as volatile but consistent with a bullish long-term structure. He emphasizes that holding above the 200-day moving average at $76.11 demonstrates resilience. The lack of adverse news flow presents opportunities for patient investors awaiting a reversal. Karapetjanc views the current phase as healthy consolidation within a broader growth context. "With the bullish trend intact above $76.11, I expect further growth opportunities to emerge once selling subsides."
Parshwa Turakhiya, analyst, observes the strong negative sentiment gripping Rocket Lab as momentum oscillators flash sell signals and support levels face pressure. Turakhiya expects choppy trading in the coming days, with price likely to hover between $76.19 and $92.21 as buyers and sellers test conviction. The absence of fresh news could mean sentiment-driven swings, setting up tactical short-term trades on volatility. "Short-term setups favor nimble players — I would look for range trades until a breakout decides the next trend leg."

Short-term weakness persists as technical indicators reinforce bearish momentum

Rocket Lab is trading below its 20-day and 50-day moving averages ($101.13 and $106.99), signaling ongoing short- and medium-term weakness, but remains above the 200-day moving average at $76.11, supporting a longer-term bullish bias. The nearest resistance is clustered at $90.44, with immediate support at $82.96 and a significant upper resistance level marked by the Ichimoku Kijun at $115.42. On the momentum side, the MACD is strongly negative, ADX shows a lack of trend strength, and most oscillators—RSI, CCI, and Stochastic RSI—indicate sell or strong sell conditions. Bull/Bear Power (BBP) is positive at 2.45, confirming some intraday buying activity, but also highlighting an overbought condition in the context of a declining market.

Previously it was reported that institutional accumulation was occurring in Rocket Lab shares despite ongoing short-term selling pressure and negative technical momentum. The latest decline intensifies the bearish outlook, making a decisive move below $76.19 a critical downside risk for traders to monitor in the near term.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.